NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough.

Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers.

This is not a job for Dr. Tolcher, it is his passion.

Clinical Trials

Health Care

Therapeutics

NEXT Oncology

Anthony Tolcher

Kimberly Fuchs

Gina Mangold

Brianne Kaiser

Shiraj S.

Cathy Alvarez

Theresa Mays

Aracely Cavazos

The Clinical Research Team at NEXT Oncology is responsible for designing, coordinating, and conducting Phase 1 clinical trials to evaluate new anticancer agents. This team includes experienced professionals such as clinical investigators, coordinators, and protocol navigators who work together to ensure that trials are conducted safely, ethically, and efficiently. Their efforts are crucial in providing cutting-edge treatment options to advanced cancer patients and advancing cancer research.

Clinical Research Team

Clinical and Regulatory Affairs

Leadership Team

Clinical Research Team

About

Team members

Other teams at NEXT Oncology

Clinical and Regulatory Affairs

Leadership Team